We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Promising Therapy for West Nile Virus

By Biotechdaily staff writers
Posted on 23 Sep 2004
A new therapy for West Nile virus (WNV), based on familiar blood-pressure drugs, has shown some promising results.

The protocol, developed by GenoMed (St. More...
Louis, MO, USA), is based on the theory that brain inflammation and death result from an over-response by the host's immune system to WNV. The company's therapy gently suppresses the immune system at an early stage in its activation.

"Thanks to clinical experience from last summer, we are getting a better picture of what angiotensin II blockade can and can't do against West Nile virus,” explained Dr. David Moskowitz, CEO and chief medical officer of GenoMed. "West Nile symptoms of ongoing infection like headache, weakness, and fatigue have gone away promptly after starting treatment.” Last summer, eight of 10 patients had disappearance of symptoms within 24 hours of taking an angiotensin II receptor blocker.

Dr. Moskowitz has been a pioneer in the field of medical genomics and has been recognized for his treatment of diseases associated with angiotensin I-converting enzyme, such as acute renal failure due to hypertension or type 2 diabetes.




Related Links:
GenoMed

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image:  Estimates suggest that 30–50% of CKD cases go undiagnosed in high‑income countries, with even higher proportions likely in middle‑ and lower‑income countries (Image Credit: Shutterstock)

Routine Urine Protein Testing Identifies Undiagnosed Chronic Kidney Disease

Chronic kidney disease (CKD) is a major cause of mortality worldwide and often progresses silently until advanced stages. Despite the availability of simple urine and blood tests, many cases remain undetected,... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.